{"product_id":"selank","title":"Selank","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eA synthetic analog of the immunomodulatory peptide tuftsin, studied for anxiolytic activity, cognitive enhancement, and BDNF modulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eWhat Is Selank?\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eSelank is a synthetic heptapeptide developed at the Institute of Molecular Genetics (Russian Academy of Sciences) as an analog of tuftsin, a naturally occurring immunomodulatory peptide. Research has documented its effects on GABA neurotransmission, BDNF expression, serotonin metabolism, and enkephalin stabilization. It has been approved as an anxiolytic medication in Russia.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eHistory\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eSelank was developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences under the direction of Academician Nikolai Myasoedov. The compound was designed by adding a Pro-Gly-Pro sequence to the C-terminus of tuftsin (Thr-Lys-Pro-Arg), creating a more stable peptide with enhanced neurotropic properties. Selank received regulatory approval in Russia in 2009 as an anxiolytic nasal spray. International research interest has grown as more studies have characterized its unique mechanism of anxiolytic action without sedation or dependency.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Protocol Aminos","offers":[{"title":"10MG","offer_id":44884459618349,"sku":null,"price":69.0,"currency_code":"COP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0744\/2232\/1197\/files\/Selank.png?v=1777403466","url":"https:\/\/protocolaminos.com\/products\/selank","provider":"Protocol Aminos","version":"1.0","type":"link"}